Neogen Q3 Earnings Call Highlights

• Food safety maturation (Q3 nutrient information gross $156.7M, +4% core) mostly offset carnal information weakness (animal information $54.5M, -8.7% core), with absorption saying the shortfall was driven by supplier disruptions alternatively than demand.

• Profitability improved arsenic adjusted EBITDA roseate to $48.2M (22.8% margin, ~110 bps sequential gain) and the institution raised full‑year gross guidance to $857–$860M portion maintaining adjusted EBITDA guidance of $175M, though currency tailwinds are expected to fade.

• The Petrifilm manufacturing transition remains connected way for November 2026 with validation and R&D enactment underway, and Neogen expects to adjacent the genomics portion merchantability (~$160M deal, ~$140M net) successful Q2 FY2027 to trim indebtedness and little nett debt/adjusted EBITDA beneath 3x.

• Interested successful Neogen Corporation? Here are 5 stocks we similar better.

Neogen (NASDAQ:NEOG) executives highlighted dependable show successful the company’s nutrient information concern and improving profitability during its fiscal 3rd 4th 2026 net call, portion acknowledging that supplier-related disruptions weighed heavy connected results successful carnal safety. Management besides provided updates connected the company’s ongoing Petrifilm manufacturing transition, translation initiatives, and the planned divestiture of its genomics unit.

CEO Mike Nassif said the institution delivered “solid halfway growth” again successful nutrient safety, including continued maturation successful the U.S., and described the quarter’s show arsenic accordant with existent marketplace dynamics. CFO Bryan Riggsbee reported full third-quarter gross of $211.2 million, representing a 0.1% summation connected a halfway basis.

→ AMC's Easter Surprise: A Bullish New Act?

Food information gross was $156.7 million, up 4% connected a halfway basis, matching the anterior quarter’s maturation complaint and “relatively successful enactment with existent marketplace maturation rates,” according to Riggsbee. He said show was led by indicator investigating and civilization media products, which were up 11%, and by “strong maturation successful pathogen trial kits.”

Animal information gross was $54.5 million, with halfway gross down 8.7% twelvemonth implicit year. Nassif said the shortfall was driven by supply-side issues alternatively than demand, and Riggsbee added that excluding the disruptions, carnal information would person been much accordant with the 2nd quarter’s year-over-year maturation profile.

→ Vertical Aerospace: The Milestone that Changes the Pitch

Nassif said Neogen improved adjusted EBITDA margins “to immoderate of the highest levels successful caller institution history” done outgo discipline. Riggsbee reported adjusted EBITDA of $48.2 million, representing a borderline of 22.8%. He said that was an betterment of astir 110 ground points sequentially contempt little revenue, driven by a diminution successful adjusted operating expenses that were down 9% from second-quarter levels.